Araştırmacı MELTEM BAY

Yayın Ağı

Makaleler 20

1. A Silver–Copper–Aluminum Layered Double Hydroxide Sensor for Sensitive Determination of Anticancer Agent Afatinib in Bulk and Biological Fluids

Gabiam E. N., ERK N., BAY M., Genc A. A., Ahmed H. E. H., SOYLAK M.

ACS Omega , cilt.10, sa.40, ss.47386-47396, 2025 (SCI-Expanded)

2. Phosphatidylserine and Tyro3-Axl-Mertk Receptor Tyrosine Kinase level detection in plasma and on plasma-derived extracellular vesicle surface in chronic lymphocytic leukemia

Bay M., Cengiz Seval G., Coşkun Ö., Gurman G., Özsoy Erdaş N.

CELL BIOCHEMISTRY AND FUNCTION , sa.4, 2024 (SCI-Expanded, Scopus)

3. Utility investigation of automated techniques in hematopoietic progenitor cell count and viability assessment in the Good Manufacturing Practice (GMP) setting

Kılıç P., Bay M., Baydın P., Şeker Ş., Coşkun Ö., Ülker O. L., et al.

Experimental Biomedical Research , cilt.3, sa.4, ss.231-238, 2020 (Hakemli Dergi)

4. A CD34+Cell Enrichment Protocol of Hematopoietic Stem Cells in a Well-Established Quality Management System

Kılıç P., Bay M., Yildirim Y., Coskun Ö., Seker Ş., Baydın P., et al.

CELLS TISSUES ORGANS , cilt.207, sa.1, ss.15-20, 2019 (SCI-Expanded)

5. Comparison of the methods evaluating post thawing viability of peripheral blood stem cell graft

Varan H. D., Bay M., Ozturk A., DALVA K., İLHAN O.

TRANSFUSION AND APHERESIS SCIENCE , cilt.58, sa.2, ss.192-195, 2019 (SCI-Expanded, Scopus)

6. Therapeutic plasmapheresis in geriatric patients: Favorable results

Ataca P., Marasuna O. A., Ayyildiz E., Bay M., İLHAN O.

TRANSFUSION AND APHERESIS SCIENCE , cilt.51, sa.3, ss.64-67, 2014 (SCI-Expanded, Scopus)

7. Therapeutic plasma exchange in treatment of neuroimmunologic disorders: Review of 92 cases

SORGUN M. H., ERDOĞAN S., Bay M., Ayyildiz E., Yucemen N., Iihan O., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.49, sa.2, ss.174-180, 2013 (SCI-Expanded, Scopus)

8. Adsorptive Leukocytapheresis in Inflammatory Bowel Diseases: Our Preliminary Results are Encouraging

TÖRÜNER M., TOPRAK S. K., Mizrak K., Yildirim Y., Bay M., Ayyildiz E., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.30, sa.2, ss.219-220, 2013 (SCI-Expanded, Scopus, TRDizin)

9. rHuEPO Hyporesponsiveness and Related High Dosages Are Associated with Hyperviscosity in Maintenance Hemodialysis Patients

Uyar M. E., TOPRAK S. K., Saglam H., Tutal E., Bay M., İLHAN O., et al.

SCIENTIFIC WORLD JOURNAL , 2013 (SCI-Expanded, Scopus)

10. Older age and capacity of colony forming unit in autologous peripheral derived hematopoietic cells

CİVRİZ BOZDAĞ S., Bay M., Ayyildiz E., Topcuoglu P., Ilhan O.

TRANSFUSION AND APHERESIS SCIENCE , cilt.47, sa.1, ss.113-116, 2012 (SCI-Expanded, Scopus)

11. Impact of age and diagnosis on viability during centrifugation and cryopreservation of peripheral blood stem cell products

CİVRİZ BOZDAĞ S., Bay M., Ayyildiz E., Topcuoglu P., Ilhan O.

TRANSFUSION AND APHERESIS SCIENCE , cilt.47, sa.1, ss.117-120, 2012 (SCI-Expanded, Scopus)

12. The effect of CD34 count and clonogenic potential of hematopoietic stem cells on engraftment

Sari T., YÜKSEL M., TOPÇUOĞLU P., Tol M., Ayyildiz E., ÖZCAN M., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.43, sa.3, ss.315-320, 2010 (SCI-Expanded, Scopus)

13. The Effect of Chronic Cadmium Toxicity on Blood Pressure and Plasma Viscosity

Kocak M. K., YAZIHAN N., Akcil E., Bay M., Aslan O.

PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS , cilt.37, sa.2-4, ss.82-87, 2009 (SCI-Expanded)

14. Comparison of different needle diameters and flow rates on bone marrow mononuclear stem cell viability: an ex vivo experimental study

Tol M., AKAR A. R., Durdu S., Ayyildiz E., Ilhan O.

CYTOTHERAPY , cilt.10, sa.1, ss.98-99, 2008 (SCI-Expanded, Scopus)

15. Impact of harvest product volume in erythrocyte depletion of allogeneic or autologous bone marrow using COBE spectra

Soydan E., Ayyildiz E., Dalva K., Topcuoglu P., Tol M., Arslan O., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.36, sa.3, ss.269-273, 2007 (SCI-Expanded, Scopus)

16. The effect of extracorporeal photoimmunotherapy (ECP) on serum TNF-a level in chronic graft versus host disease (GvHD)

Ayyildiz E., Arslan O., Topcuoglu P., Arat M., Dalva K., Soydan E. A., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.36, sa.1, ss.79-85, 2007 (SCI-Expanded, Scopus)

17. Impact of product volume in erythrocyte depletion of bone marrow harvest using Cobe spectra.

Ayyildiz E., Soydan E., Gokce S., Yildirim Y., Tol M., Arat M., et al.

CYTOTHERAPY , cilt.8, 2006 (SCI-Expanded)

18. The effect of needle diameter on hematopoietic stem cell viability in hematopoetic stem cell applications (ex vivo experimental study).

Tol M., AKAR A. R., Durdu S., Ayyildiz E., Topcuoglu P., YÜKSEL M., et al.

CYTOTHERAPY , cilt.8, 2006 (SCI-Expanded)

19. Allogeneic Hemapoietic Progenitor Cell Collection Using Four Different Cell Separators: A Retrospective Comparative Analysis.

Arat M., Arslan O., Soydan E. A., Ayyildiz E., Dalva K., Tol M., et al.

BLOOD , cilt.104, sa.11, ss.5009, 2004 (SCI-Expanded)

20. Effects of replacement fluids used for therapeutic plasma exchange on plasma viscosity and plasma oncotic pressure

Tek I., Arslan O., Arat M., Ayyildiz E., Tol M., Oral M., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.31, sa.2, ss.89-93, 2004 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 14

1. Phosphatidylserine (PS) and Tyro3-Axl-Mertk (TAM) Receptor Tyrosine Kinase (RTK) Levels Detection and Exosomes Surface in Chronic Lymphocyctic Leukemia (CLL)

Bay M., Cengiz Seval G., Coşkun Ö., Gürman G., Özsoy Erdaş N.

International Congress of Health Research , Ankara, Türkiye, 8 - 09 Aralık 2022, ss.33-34, (Özet Bildiri)

2. s it possible to overcome the catastrophic complications of Hematopoietic Stem Cell Transplantation HSCT using Plasma Exchange PE A Single Center s Experience

YÜKSEL M., Gultekin G., Edipoglu E., Bay M., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.

41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, 22 - 25 Mart 2015, (Özet Bildiri)

3. Are there any optimal cell doses for graft repopulation in the Bone Marrow-Derived Allogeneic Hematopoietic Stem Cell Transplantations?

Ataca P., Atilla E., Altas U., Bay M., Dalva K., CİVRİZ BOZDAĞ S., et al.

41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015, cilt.50, (Özet Bildiri)

4. Is it possible to overcome the catastrophic complications of Hematopoietic Stem Cell Transplantation (HSCT) using Plasma Exchange (PE)?: A Single Center's Experience

YÜKSEL M., Pekcan G., Ediboglu E., Bay M., Civriz S., TOPRAK S. K., et al.

41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015, cilt.50, ss.5581-5582, (Özet Bildiri)

5. Is there an optimum CD3+T cell dose for donor lymphocyte infusion?

CİVRİZ BOZDAĞ S., Kircali E., Ataca P., Atilla E., Bay M., TOPRAK S. K., et al.

41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015, cilt.50, ss.5598, (Özet Bildiri)

6. Graft content and engraftment relationship in allogeneic bone marrow transplantation

CİVRİZ BOZDAĞ S., Topcuoglu P., Bay M., Ayyildiz E., Arslan O., Beksac M., et al.

39th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT), London, Kanada, 7 - 10 Nisan 2013, cilt.48, (Özet Bildiri)

7. FACTORS INFLUENCING HYPERVISCOSITY IN MAINTENANCE HEMODIALYSIS PATIENTS

Uyar M. E., TOPRAK S. K., Saglam H., Tutal E., Bay M., İLHAN O., et al.

49th Congress of the European-Renal-Association/European-Dialysis-and-Transplant-Association (ERA-EDTA), Paris, Fransa, 24 - 27 Mayıs 2012, cilt.27, ss.516, (Özet Bildiri)